NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

I agree alphapuppy, also I noticed that the mOS for the control group in your modeling was about 19.7 months. This is significantly higher than the historical mOS average for SOC (Stupp protocol) since 2005. The historical mOS average is 14 to 16 months.

I assume your mOS average of 19.7 months for the control group in your model was impacted by the crossover effect. If NWBio is able to eliminate the crossover effect in its analysis, the mOS for the control group should be less than 19.7 months, and closer to the historical average of 14 to 17 months. If the control group mOS in your model goes down, closer to the historical mOS, I assume the treatment group mOS in your model would increase.

Do you agree with that?